304 related articles for article (PubMed ID: 31398338)
1. The Oncogenic Action of NRF2 Depends on De-glycation by Fructosamine-3-Kinase.
Sanghvi VR; Leibold J; Mina M; Mohan P; Berishaj M; Li Z; Miele MM; Lailler N; Zhao C; de Stanchina E; Viale A; Akkari L; Lowe SW; Ciriello G; Hendrickson RC; Wendel HG
Cell; 2019 Aug; 178(4):807-819.e21. PubMed ID: 31398338
[TBL] [Abstract][Full Text] [Related]
2. TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway.
Liu Y; Tao S; Liao L; Li Y; Li H; Li Z; Lin L; Wan X; Yang X; Chen L
Nat Commun; 2020 Jan; 11(1):348. PubMed ID: 31953436
[TBL] [Abstract][Full Text] [Related]
3. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
4. Increased protein glycation in fructosamine 3-kinase-deficient mice.
Veiga da-Cunha M; Jacquemin P; Delpierre G; Godfraind C; Théate I; Vertommen D; Clotman F; Lemaigre F; Devuyst O; Van Schaftingen E
Biochem J; 2006 Oct; 399(2):257-64. PubMed ID: 16819943
[TBL] [Abstract][Full Text] [Related]
5. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
[TBL] [Abstract][Full Text] [Related]
6. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells.
Sun X; Ou Z; Chen R; Niu X; Chen D; Kang R; Tang D
Hepatology; 2016 Jan; 63(1):173-84. PubMed ID: 26403645
[TBL] [Abstract][Full Text] [Related]
7. NRF2 DLG Domain Mutations Identified in Japanese Liver Cancer Patients Affect the Transcriptional Activity in HCC Cell Lines.
Haque E; Śmiech M; Łuczyńska K; Bouchard MF; Viger R; Kono H; Pierzchała M; Taniguchi H
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069882
[TBL] [Abstract][Full Text] [Related]
8. Screening fructosamine-3-kinase (FN3K) inhibitors, a deglycating enzyme of oncogenic Nrf2: Human FN3K homology modelling, docking and molecular dynamics simulations.
Beeraka NM; Zhang J; Mandal S; Vikram P R H; Liu J; B M N; Zhao D; Vishwanath P; B M G; Fan R
PLoS One; 2023; 18(11):e0283705. PubMed ID: 37910519
[TBL] [Abstract][Full Text] [Related]
9. Comparative subcellular localization of NRF2 and KEAP1 during the hepatocellular carcinoma development in vivo.
Guerrero-Escalera D; Alarcón-Sánchez BR; Arellanes-Robledo J; Cruz-Rangel A; Del Pozo-Yauner L; Chagoya de Sánchez V; Resendis-Antonio O; Villa-Treviño S; Torres-Mena JE; Pérez-Carreón JI
Biochim Biophys Acta Mol Cell Res; 2022 May; 1869(5):119222. PubMed ID: 35093454
[TBL] [Abstract][Full Text] [Related]
10. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells.
Inami Y; Waguri S; Sakamoto A; Kouno T; Nakada K; Hino O; Watanabe S; Ando J; Iwadate M; Yamamoto M; Lee MS; Tanaka K; Komatsu M
J Cell Biol; 2011 Apr; 193(2):275-84. PubMed ID: 21482715
[TBL] [Abstract][Full Text] [Related]
11. S-1-propenylmercaptocysteine protects murine hepatocytes against oxidative stress via persulfidation of Keap1 and activation of Nrf2.
Tocmo R; Parkin K
Free Radic Biol Med; 2019 Nov; 143():164-175. PubMed ID: 31349040
[TBL] [Abstract][Full Text] [Related]
12. GSTZ1-1 Deficiency Activates NRF2/IGF1R Axis in HCC via Accumulation of Oncometabolite Succinylacetone.
Yang F; Li J; Deng H; Wang Y; Lei C; Wang Q; Xiang J; Liang L; Xia J; Pan X; Li X; Long Q; Chang L; Xu P; Huang A; Wang K; Tang N
EMBO J; 2019 Aug; 38(15):e101964. PubMed ID: 31267557
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of phosphorylated p62 is associated with NF-E2-related factor 2 activation in hepatocellular carcinoma.
Shimizu T; Inoue K; Hachiya H; Shibuya N; Aoki T; Kubota K
J Hepatobiliary Pancreat Sci; 2016 Aug; 23(8):467-71. PubMed ID: 27246794
[TBL] [Abstract][Full Text] [Related]
14. Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites.
Delpierre G; Veiga-da-Cunha M; Vertommen D; Buysschaert M; Van Schaftingen E
Diabetes Metab; 2006 Feb; 32(1):31-9. PubMed ID: 16523184
[TBL] [Abstract][Full Text] [Related]
15. The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system.
Copple IM; Goldring CE; Jenkins RE; Chia AJ; Randle LE; Hayes JD; Kitteringham NR; Park BK
Hepatology; 2008 Oct; 48(4):1292-301. PubMed ID: 18785192
[TBL] [Abstract][Full Text] [Related]
16. Some clues as to the regulation, expression, function, and distribution of fructosamine-3-kinase and fructosamine-3-kinase-related protein.
Conner JR; Beisswenger PJ; Szwergold BS
Ann N Y Acad Sci; 2005 Jun; 1043():824-36. PubMed ID: 16037310
[TBL] [Abstract][Full Text] [Related]
17. Possible role of fructosamine 3-kinase genotyping for the management of diabetic patients.
Avemaria F; Carrera P; Lapolla A; Sartore G; Chilelli NC; Paleari R; Ambrosi A; Ferrari M; Mosca A
Clin Chem Lab Med; 2015 Aug; 53(9):1315-20. PubMed ID: 26352355
[TBL] [Abstract][Full Text] [Related]
18. Molecular Mechanisms Underlying Hepatocellular Carcinoma Induction by Aberrant NRF2 Activation-Mediated Transcription Networks: Interaction of NRF2-KEAP1 Controls the Fate of Hepatocarcinogenesis.
Haque E; Karim MR; Salam Teeli A; Śmiech M; Leszczynski P; Winiarczyk D; Parvanov ED; Atanasov AG; Taniguchi H
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751080
[TBL] [Abstract][Full Text] [Related]
19. The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers.
Beeraka NM; Bovilla VR; Doreswamy SH; Puttalingaiah S; Srinivasan A; Madhunapantula SV
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33466626
[TBL] [Abstract][Full Text] [Related]
20. Tiliroside targets TBK1 to induce ferroptosis and sensitize hepatocellular carcinoma to sorafenib.
Yang C; Lu T; Liu M; Yuan X; Li D; Zhang J; Zhou L; Xu M
Phytomedicine; 2023 Mar; 111():154668. PubMed ID: 36657316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]